Electronic feta l heart rate (FHR) monitoring was introduced in the late 1960s with the hope of preventing intrapartum fetal brain injury and cerebral palsy (CP). However, it is now clear that this hope was unrealistic for at least 2 reasons. First, the false-positive rate of intrapartum FHR monitoring for predicting CP exceeds 99%. Except in the most extreme cases, intrapartum FHR monitoring has never been capable of reliably predicting CP.
Electronic fetal heart rate (FHR) monitoring was introduced in the late 1960s with the hope of preventing intrapartum fetal brain injury and cerebral palsy (CP).1 However, it is now clear that this hope was unrealistic for at least 2 reasons. First, the false-positive rate of intrapartum FHR monitoring for predicting CP exceeds 99%.2 Except in the most extreme cases, intrapartum FHR monitoring has never been capable of reliably predicting CP. Second, most cases of CP originate outside the intrapartum period and therefore cannot be prevented by any form of intrapartum monitoring or intervention.3
A growing body of evidence indicates that standardization of intrapartum management can reduce adverse outcomes and professional liability claims.4,5 However, for many years, standardization of FHR monitoring was impeded by lack of consensus. Without evidence-based standardization, clinicians were left without clear guidance and often found themselves facing unfounded accusations of mismanagement.
Standardized definitions
Standardized interpretation
Scientific evidence and consensus in the literature can distill intrapartum FHR interpretation into 3 central concepts.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More